Table 3

Absolute and relative risks for VTE in relatives dependent on IT

Type of ITExposure time, yEvent, nAnnual incidence, % (95% CI)Hazard ratio,* % (95% CI)P
AT/PC/PS 463 13 2.82 (1.63-4.80) 25.7 (12.2-54.2) < .001 
FV G1691A 2783 0.25 (0.12-0.53) 1.7 (0.7-4.4) .24 
FII G20210A 1192 0.42 (0.17-1.01) 2.6 (0.9-7.6) .09 
Combined defects 258 2.33 (1.04-5.19) 19.6 (7.7-49.6) < .01 
No IT 13 567 14 0.10 (0.06-0.17) 
Total 18 278 47 0.26 (0.19-0.34)   
Type of ITExposure time, yEvent, nAnnual incidence, % (95% CI)Hazard ratio,* % (95% CI)P
AT/PC/PS 463 13 2.82 (1.63-4.80) 25.7 (12.2-54.2) < .001 
FV G1691A 2783 0.25 (0.12-0.53) 1.7 (0.7-4.4) .24 
FII G20210A 1192 0.42 (0.17-1.01) 2.6 (0.9-7.6) .09 
Combined defects 258 2.33 (1.04-5.19) 19.6 (7.7-49.6) < .01 
No IT 13 567 14 0.10 (0.06-0.17) 
Total 18 278 47 0.26 (0.19-0.34)   

IT indicates inherited thrombophilia; and VTE, venous thromboembolism.

*

Adjusted for age and sex.

Close Modal

or Create an Account

Close Modal
Close Modal